Business Context and Reporting Period
This Form 6-K filing by Fresenius Medical Care AG & Co. KGaA covers the month of November 2016. The report focuses exclusively on legal and regulatory matters regarding an ongoing settlement process, rather than providing a comprehensive financial update.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as an update to a previous filing and contains no new financial data.
Material Changes
The primary material change reported is an amendment to the opt-in process schedule for a settlement agreement, approved by the Court. Key timeline adjustments include:
- Plaintiffs must advise the company of settlement acceptances by January 6, 2017.
- The company has until January 27, 2017, to exercise rights to void the settlement.
- Payment of the settlement amount is due by February 3, 2017, if confirmed.
- Trials for cases not participating in the settlement are scheduled to resume on February 6, 2017.
Outlook, Risks, and Contingencies
Management notes that additional incidental changes to the settlement schedule are likely to occur. The filing highlights the contingency of the settlement confirmation and the potential resumption of litigation for non-participating cases.
Investor Verification Checklist
- Verify the final confirmation status of the settlement by the February 3, 2017 payment deadline.
- Monitor for any further amendments to the opt-in process schedule.
- Review the original October 2016 Form 6-K for the initial agreement details and financial context.
- Track the resumption of trials for non-settling cases starting February 6, 2017.